SCHEMBL4896964

SCHEMBL4896964

CCCCCCCCCCC1CCC([O])CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.48
HTT P42858 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TP53 P04637 1/20 0.44
PKM P14618 1/20 0.44
EPHX1 P07099 1/20 0.43
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LSS P48449 2/20 0.40
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
MAPT P10636 1/20 0.40
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
ALOX5 P09917 1/20 0.37
S1PR2 O95136 1/20 0.37
S1PR4 O95977 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11831050 1.00 CYP1A2 (0.48) CYP1A2HTTMEN1KMT2ATP53
SCHEMBL1532927 0.98 CYP1A2 (0.50) CYP1A2HTTMEN1KMT2ATP53
SCHEMBL1008791 0.91 CYP1A2 (0.58) CYP1A2HTTMEN1KMT2ATP53
SCHEMBL6031279 0.88 CYP1A2 (0.59) CYP1A2HTTMEN1KMT2ATP53
SCHEMBL1847927 0.88 CYP1A2 (0.59) CYP1A2HTTMEN1KMT2ATP53
SCHEMBL5807045 0.88 CYP1A2 (0.59) CYP1A2HTTMEN1KMT2ATP53
SCHEMBL6753110 0.88 CYP1A2 (0.59) CYP1A2HTTMEN1KMT2ATP53
SCHEMBL6749100 0.88 CYP1A2 (0.59) CYP1A2HTTMEN1KMT2ATP53
SCHEMBL997470 0.88 CYP1A2 (0.59) CYP1A2HTTMEN1KMT2ATP53
SCHEMBL2048536 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220413384-A1 PHOTOSENSITIVE COMPOSITION, FILM, OPTICAL FILTER, SOLID-STATE IMAGING ELEMENT, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2022-12-29 US disclosed
US-20150004486-A1 COMPOSITION FOR FORMING SECONDARY CELL ELECTRODE, SECONDARY CELL ELECTRODE, AND SECONDARY CELL TOYO INK SC HOLDINGS CO., LTD. (JP) 2015-01-01 US disclosed
EP-2811550-A1 COMPOSITION FOR FORMING SECONDARY CELL ELECTRODE, SECONDARY CELL ELECTRODE, AND SECONDARY CELL Toyo Ink SC Holdings Co., Ltd. (JP) 2014-12-10 EP disclosed
US-8895632-B2 Anthracene derivative, compound obtained therefrom, composition, cured product, and process for producing same ASAHI ORGANIC CHEMICALS INDUSTRY CO., LTD. (JP) 2014-11-25 US disclosed
US-20120232240-A1 ANTHRACENE DERIVATIVE, COMPOUND OBTAINED THEREFROM, COMPOSITION,CURED PRODUCT, AND PROCESS FOR PRODUCING SAME ASAHI ORGANIC CHEMICALS INDUSTRY CO., LTD. (JP) 2012-09-13 US disclosed
US-20080044149-A1 Polymerizable Composition TOYO INK MFG. CO., LTD. (JP) 2008-02-21 US disclosed
EP-1816152-A1 POLYMERIZABLE COMPOSITION TOYO INK MFG. CO., LTD. (JP) 2007-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120232240-A1 ANTHRACENE DERIVATIVE, COMPOUND OBTAINED THEREFROM, COMPOSITION,CURED PRODUCT, AND PROCESS FOR PRODUCING SAME AHR, CYP1A1, CYP2F1 CYP1A2 9/4885HTT 3292/4885MEN1 4699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.